Moreover, combining this approach with PD-1/PD-L1 blockade effectively promotes CD8+ T cell infiltration into the tumor microenvironment, thereby triggering a robust systemic immune response capable of suppressing the progression of distant tumors. This evidence concerns the gene CD274 and neoplasm.